Monographie - Azacitidine

Senaste uppdateringen :
19/11/2024

Azacitidine

Molekylstruktur

Varunamn

Angivna handelsnamn på läkemedel är enbart vägledande då formulering inklusive hjälpämnen kan variera mellan länder och tillverkare

Amilix	Argentina
Arquimes	Argentina
Azacimyl	Chile
Azacitidina	Argentina, Chile, Peru
Azacitidine	Förenta Staterna
Azacor	Peru
Azadin	Turkiet
Azamex	Argentina
Azanova	Argentina
Azateva	Argentina
Azida	Turkiet
Azitech	Argentina
Iclacitidina	Peru
Iterbil	Argentina
Maturus	Argentina
Mietozitidina	Argentina, Peru
Nimodac	Argentina
Remitiva	Argentina, Chile
Tazadir	Argentina
Vidaza	Argentina, Belgien, Chile, Colombia, Förenta Staterna, Frankrike, Island, Kanada, Malaysia, Mexiko, Norge, nya Zeeland, Peru, Rumänien, Schweiz, Spanien, Storbritannien, Turkiet, Tyskland
Wunduza	Chile
Zacidonel	Mexiko
Zylatadina	Argentina

Hänvisningar : Azacitidine

	Typ	Publikation
414	tidningen	Den Hartigh J, Brandenburg HCR, Vermeij P. Stability of azacitidine in lactated Ringer’s injection frozen in polypropylene syringes. Am J Hosp Pharm 1989 ; 46: 2500-2505.
1039	tidningen	Cheung YW, Vishnuvajjala BR, Morris NL, Flora KP. Stability of azacitidine in infusion fluids. Am J Hosp Pharm 1984 ; 41: 1156-1159.
3204	tidningen	Duriez A, Vigneron J.H, Zenier H.A, May I, Demoré B.M. Stability of Azacitidine Suspensions. Ann Pharmacotherapy 2011 ;45, 4:546.
3236	Laboratorium	Azacitidine (Vidaza®) - Résumé des caractéristiques du produit Celgene 2011
3246	affisch	Vieillard V, Appudurai O, Voytenko S, Astier A, Paul M. Stabilité physico-chimique de la suspension d'azacitidine (25 mg/mL) conservée à 4°C. SFPO Congress Mandelieu, France 2011
3351	tidningen	Walker S.E, Charbonneau L.F, Law S, Earle C. Stability of Azacitidine in Sterile Water for Injection. Can J Hosp Pharm 2012 ; 65, 5: 352-359
3534	tidningen	Legeron R, Xuereb F, Djabarouti S, Saux M.C, Breilh D. Chemical stability of azacitidine suspensions for injection after cold-chain reconstitution of powder and storage Am J Health-Syst Pharm 2013 ; 70:2137-2142
3816	affisch	Balouzet C, Chanat C, Jobard M, Brandely-Piat ML, Chast F. Stabilité des poches d'azacitidine pour injection intraveineuse (1- 4 et 2,4 mg/mL) conservées à 4°C. SFPO Congress, Nantes, France 2015
3818	tidningen	Balouzet C, Chanat C, Jobard M, Brandely-Piat M-L, Chast F. Stability of 25 mg/mL 5-azacitidine suspension kept in fridge after freezing. Pharmaceutical Technology in Hospital Pharmacy 2017 ;2, 1:11-16.
4227	affisch	Tyono I, Law S, Charbonneau L.F, Walker S.E. Stability of Azacitidine Solutions In Sterile Water for Injection. Prof Practice Conference - Canadian Society of PH 2019
4628	tidningen	Iudicello A, Genovese F, Strusi V, Dominici M, Ruozi B. Development and Validation of a New Storage Procedure to Extend the In-Use Stability of Azacitidine in Pharmaceutical Formulations. Pharmaceuticals 2021 ; 14, 943.
4697	tidningen	Trambloy Q, Vigneron J, Clarot I, Blaise F, D’Huart E, Demoré B. Physicochemical stability of azacitidine suspensions at 25 mg/mL in polypropylene syringes stored under different conditions of storage. Pharmaceutical Technology in Hospital Pharmacy 2022 2022; 7(1): 20220003

Mentions Légales